Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STERIS plc Director's Dealing 2022

Aug 5, 2022

30229_dirs_2022-08-05_43881b4d-642e-4ff7-8f96-deee302d05b5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS plc (STE)
CIK: 0001757898
Period of Report: 2022-08-03

Reporting Person: KOSECOFF JACQUELINE B (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-08-03 Director Stock Option (right to buy) $203.00 A 1869 Acquired 2032-08-03 Ordinary Shares (1869) Direct
2022-08-03 Director Stock Option (right to buy) $203.00 A 321 Acquired 2032-08-03 Ordinary Shares (321) Direct
2022-08-03 Career Restricted Stock Units $ A 573 Acquired Ordinary Shares (573) Direct
2022-08-03 Career Restricted Stock Units $ A 404 Acquired Ordinary Shares (404) Direct

Footnotes

F1: These nonqualified stock options are fully vested and are exercisable immediately.

F2: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $20,000.

F3: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.

F4: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.

F5: These Career Restricted Stock Units were issued to the Reporting Person in lieu of $82,000 in fees.